Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Laurus Labs Ltd - 540222 - Closure of Trading Window

 Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, the trading window for dealing in the shares of the Company shall remain closed from April 01, 2023 till 48 hours after the declaration of audited financial results for the quarter and year ended March 31, 2023. The date of Board Meeting of the Company for consideration and approval of the audited financial results for the quarter and year ended March 31, 2023 will be intimated later. This is for your information and records.
31-03-2023

Brokerage further cuts price target on Laurus Labs, see details here

 The brokerage has also cut its target price on the stock from 350 per share earlier to 295 per share.
29-03-2023

Time for pharma industry to move from Make in India to Invent in India: Laurus Labs CEO

 The government should look into incentivising disruptive research in the healthcare sector, says Satyanarayana Chava, the founder of the Hyderabad-based company that sells active pharmaceutical ingredients in over 55 countries.
14-03-2023
Bigul

Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Motilal Oswal - Investors' Group Meetings on March 13, 2023
13-03-2023
Bigul

Laurus Labs Ltd - 540222 - Outcome Of Postal Ballot Process By Way Of E-Voting

 Pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find enclosed the voting results (Annexure A) along with Scrutinizer Report (Annexure B) in respect of the Special Resolution relating to 'the re-appointment of Dr. Venkata Lakshmana Rao Chunduru (DIN 06885453) as Executive Director of the Company' passed through postal ballot by way of remote e-voting as per the postal ballot notice of the Company dated January 30, 2023 and the resolution has been passed by Members with requisite majority. This is for your information and records.
10-03-2023
Bigul

Laurus Labs Ltd - 540222 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 This is to inform you that the United States Food & Drug Administration (USFDA) today completed inspection of our formulations manufacturing facility Unit-2, APSEZ, Atchutapuram, Visakhapatnam, Andhra Pradesh. The inspection was conducted from 6th February, 2023 to 10th February, 2023. We have been issued a Form 483 with two observations. The observations are procedural in nature. The Company will address the observations within stipulated timelines.
10-02-2023
Bigul

Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Please find enclosed the newspaper advertisement regarding the 'Postal Ballot Notice' seeking the approval of shareholders for the reappointment of Dr. Chunduru Venkata Lakshmana Rao (DIN 06885453) as Executive Director of the Company for further period of 5 years from March 08, 2023 through e-voting process. The Advertisement appeared in the Business Standard (English Newspaper) and Prajasakthi (Telugu Newspaper) on February 07, 2023. The same is also available on the Company's website at www.lauruslabs.com. Please take the information on record.
07-02-2023
Bigul

Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Antique Annual Conference conducted on Feb 06, 2023
06-02-2023
Bigul

Laurus Labs Ltd - 540222 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

 Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, please find enclosed the Postal Ballot Notice seeking approval of members of the Company, through remote e-voting as Special Resolution to approve the re-appointment of Dr. Chunduru Venkata Lakshmana Rao (DIN 06885453) as Executive Director of the Company for further period of 5 years from March 08, 2023.
06-02-2023
Bigul

Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

 Transcript of Q3 FY ''23 Earnings Conference Call hosted on January 30, 2023
04-02-2023
Next Page
Close

Let's Open Free Demat Account